VenuGopalBathiniMD
Oncology • Framingham, MAAssistant Professor, Medicine, University Massachusetts Medical School
Dr. Bathini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
571 Union Ave
Ste 202
Framingham, MA 01702Phone+1 508-665-6261Fax+1 508-665-4175
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2003 - 2006
Beth Israel Deaconess Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003- UMass Chan Medical SchoolResidency, Internal Medicine, 1999 - 2002
Chicago Medical School/Rosalind Franklin University of Medicine ScienceInternship, Transitional Year, 1998 - 1999
Kakatiya Medical College NTRClass of 1995
Certifications & Licensure
MA State Medical License 2002 - 2025
FL State Medical License 2006 - 2010
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Trial of Chemo & Radiation Therapy for Pancreatic Cancer Start of enrollment: 2006 Jun 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 12 citationsCoordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.Lacey J. McIntosh, Max P. Rosen, Kriti Mittal, Giles F. Whalen, Venu Bathini
Cancer Treatment Reviews. 2021-05-11 - 20 citationsMolecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.Xiaoqin Zhu, Sarah Jamshed, Jian Zou, Azniv Azar, Xiuling Meng
Modern Pathology. 2021-01-22 - 3 citationsUtility of HNF-1B and a panel of lineage-specific biomarkers to optimize the diagnosis of pancreatic ductal adenocarcinoma.Shi Bai, James Lindberg, Giles F. Whalen, Venu Bathini, Jian Zou
American Journal of Cancer Research. 2021-01-01
Journal Articles
- Original Contribution Heterogeneous Mutational Profile and Prognosis Conferred by TP53 Mutations in Appendiceal Mucinous Neoplasms☆Ediz F Cosar, Mohammed Salhab, Otto Walter, Laura A Lambert, Carol Mathew, Xiaofei Wang, Venu Bathini, ScienceDirect
Press Mentions
University of Massachusetts Hematology Oncology FellowshipApril 30th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
